FDA Renames Grandfathered Tobacco Products as Pre-existing Products

Aug.25.2022
FDA Renames Grandfathered Tobacco Products as Pre-existing Products
The US FDA renames "grandfathered tobacco products" to "pre-existing tobacco products" to align with current regulations.

The US Food and Drug Administration's Center for Tobacco Products (CTP) has updated the term "grandfathered tobacco product" to "pre-existing tobacco product" to more accurately describe these products.


Image: Olivier Le Moal


According to the US Food and Drug Administration, the term "grandfathered" originated from 19th century racist voting laws and is used to describe people or things that are not subject to new laws or regulations. Grandfathered tobacco products or pre-existing tobacco products refer to any tobacco products that were already on the market in the United States prior to February 15, 2007, including those in test markets, and do not require premarket tobacco product application (PMTA) approval.


Submitting a request for confirmation of pre-existing tobacco products is voluntary and not required by the Federal Food, Drug, and Cosmetic Act. According to the CTP, updating terminology does not require companies previously confirmed as "grandfathered tobacco products" to take any additional action.


Statement


This article has been compiled from third-party information for the sole purpose of industry communication and learning.


This article does not represent the viewpoint of 2FIRSTS and the company cannot confirm the accuracy or truthfulness of its content. The translation of this article is solely for industry research and communication purposes.


Due to limitations in the level of translation ability, the translated article may not perfectly reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on all domestic, Hong Kong, Macao and Taiwan-related, and foreign-related views and positions.


The compilation of information is copyrighted to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Opinion | Samrat Chowdhery: Tobacco Price Elasticity—A Convenient Myth?
Opinion | Samrat Chowdhery: Tobacco Price Elasticity—A Convenient Myth?
This opinion piece, submitted by Samrat Chowdhery to 2Firsts, challenges the logic of tobacco price elasticity. It argues that high taxes often harm vulnerable populations and fuel illicit markets rather than reducing smoking.
Oct.21
Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s Nicotine Pouch Rollout in the U.S.: On! PLUS May Launch on October 14, Not Yet FDA-Approved
Altria’s new nicotine pouch On! PLUS™ is slated to launch in the U.S. on October 14, debuting in North Carolina, Texas, and Florida. The product uses NICOSILK™ technology and will offer multiple nicotine strengths. FDA approval has not yet been granted, but Helix says it is proceeding in line with compliance requirements.
Oct.11 by 2FIRSTS.ai
PMI Q3 2025 Earnings: Net Revenues Reach $10.85 Billion, Smoke-Free Products Account for 41% of Sales
PMI Q3 2025 Earnings: Net Revenues Reach $10.85 Billion, Smoke-Free Products Account for 41% of Sales
PMI reported strong third-quarter 2025 results, underscoring the continued success of its smoke-free transformation. Net revenues rose 9.4% year-over-year to $10.85 billion, driven by robust growth in the smoke-free segment, which now accounts for 41% of total net revenues and over 42% of gross profit.Despite a 3.2% decline in cigarette shipments, combustible revenues climbed 4.3% thanks to strong pricing.
Oct.21
UK Peer Seeks to Weaken “Generational Smoking Ban” – Report Reveals Discussions with BAT Executive Relative
UK Peer Seeks to Weaken “Generational Smoking Ban” – Report Reveals Discussions with BAT Executive Relative
Lord Strathcarron, a member of the UK House of Lords, has admitted to discussing the government’s Tobacco and Vapes Bill with a relative who holds a senior role at British American Tobacco (BAT). He is advocating amendments to scrap the bill’s core “generational smoking ban” provision, raising questions of potential conflict of interest.
Oct.27
Russian State Duma considers regulations to address widespread use of e-cigarettes among youth
Russian State Duma considers regulations to address widespread use of e-cigarettes among youth
Russian Duma considers comprehensive regulations to address widespread e-cigarette use among youth, including potential sales bans and flavor restrictions.
Oct.20 by 2FIRSTS.ai
German tobacco industry leaders gathered at InterTabac to criticize the EU tax reform proposal: high taxes will kill the nicotine pouch industry and hurt fiscal revenue
German tobacco industry leaders gathered at InterTabac to criticize the EU tax reform proposal: high taxes will kill the nicotine pouch industry and hurt fiscal revenue
At the InterTabac opening press conference, German tobacco industry leaders criticized the EU’s proposed tax reform, warning that steep hikes could devastate the nicotine pouch sector, reduce excise revenue, and fuel illicit trade. They called on German policymakers to oppose the changes at the European level.
Sep.19